Documentdetail
ID kaart

doi:10.1186/s12894-023-01191-z...

Auteur
Zhang, Junlong Zeng, Qinsong Kang, Jihui Chen, Junxing Luo, Guiyuan Liang, Yueyou
Langue
en
Editor

BioMed Central

Categorie

Urology

Jaar

2023

vermelding datum

08-03-2023

Trefwoorden
duplex kidney primary retroperitoneal mucinous c... surgical approach cystic borderline tumours malignancy primary mucinous retroperitoneal
Metriek

Beschrijving

Background Primary retroperitoneal mucinous cystic tumours with borderline malignancy (PRMC-BM) are rare and difficult to diagnose preoperatively.

We are the first to report two cases of PRMC-BM which mimic a duplex kidney and evaluate the outcomes of different surgical procedures.

Case presentation We describe two cases of retroperitoneal cystic tumours.

Both were diagnosed with duplex kidney with hydronephrosis on computed tomography scan.

The first patient underwent robot-assisted laparoscopic surgery and was found to have a retroperitoneal cystic tumour.

The other patient underwent an ultrasound-guided puncture before surgery and was diagnosed with retroperitoneal lymphangioma.

Retroperitoneal cystectomy was performed using an open transperitoneal procedure.

The final pathologic diagnosis in both cases implies PRMC-BM.

The open surgical approach was associated with a shorter operation time, less intraoperative blood loss, and protected cyst wall integrity by comparing the different surgical approaches.

During follow-up, the patient in the first case had tumour recurrence six months post-surgery, and the other patient was healthy without recurrence or metastasis 12 months post-surgery.

Conclusions Primary retroperitoneal mucinous cystic tumours with borderline malignancy can be enclosed within the kidney and misdiagnosed as other cystic diseases of the urinary system.

Thus, an open surgical approach may be more suitable for this type of tumour.

Zhang, Junlong,Zeng, Qinsong,Kang, Jihui,Chen, Junxing,Luo, Guiyuan,Liang, Yueyou, 2023, Primary retroperitoneal mucinous cystic tumour of borderline malignancy mimicking kidney duplicate: cases report and literature review, BioMed Central

Document

Openen

Delen

Bron

Artikelen aanbevolen door ES/IODE AI

Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial
gravis myasthenia study clinical phase baseline improvement mg-adl 340 week trial placebo period mg maintenance qw